Concepedia

Spyridon Gkalpakiotis

SG

24

Publications

660

Citations

15

H-Index

2007

Active since

Affiliations

Charles University(Current)

University Hospital Kralovske Vinohrady

Apigenex (Czechia)

General University Hospital in Prague

University of Toronto

Spyridon Gkalpakiotis is an author at Charles University specializing in medicine, dermatology, and immunology.

ORCID

Top concepts

Publications per year

2007–2024

24

Publications

24

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2021 · 112 citations · Full text

, , +6

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2022 · 73 citations · Full text

, , +7

Effective long‐term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy

Monika Arenbergerová, Spyridon Gkalpakiotis, Petr Arenberger · International Journal of Dermatology · 2010 · 50 citations

Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic

Spyridon Gkalpakiotis, Petra Cetkovská, Petr Arenberger et al. · Dermatology and Therapy · 2021 · 47 citations · Full text

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real‐life data from PSONET registries

Celine Busard, Arnon D. Cohen, Peter Wolf et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 38 citations

Rows per page

1–5 of 24